Investors are rushing into the relative safe haven of the bond market, causing the yield on the U.S. 10-year Treasury to plummet.Real Estateread more
President Donald Trump on Thursday directed the U.S. intelligence community to "quickly and fully cooperate" with Attorney General William Barr's investigation into the...Politicsread more
The embattled leader is expected to outline a timetable for her successor to be chosen.Europe Politicsread more
Despite a decline in global commercial real estate markets, Asia-Pacific continues to enjoy a record-breaking growth — thanks to China, according to the Global Capital Flows...Real Estateread more
The Wall Street Journal and The New York Times, citing people familiar with the deal, reported that $30 million would go to plaintiffs and $14 million would be used to pay...Entertainmentread more
Danish shipping group A.P. Moller-Maersk on Friday posted first-quarter profit close to expectations and warned that trade tensions and slowing economic growth constitute...Earningsread more
Wall Street is becoming convinced that both the White House and Beijing are willing to engage in a protracted trade war that could begin to hit consumers and slow global...Market Insiderread more
The U.S. Commerce Department said its proposed rule would amend the normal countervailing duty process to include new criteria for currency undervaluation.World Economyread more
SpaceX sent 60 satellites into space in a key first mission toward the company's own high-speed internet network.Internetread more
Zilingo founder Ankiti Bose says working as an investment analyst helped her build her near-$1 billion fashion start-up.Ditching the Corporate Liferead more
TransferWise, the money transfer start-up, was valued at $3.5 billion after investors bought $292 million of shares in a secondary sale.Technologyread more
Pfizer said on Wednesday it would reorganize into three units, separating its consumer health-care business that the U.S. drugmaker has been trying to sell since last year.
The news comes a day after the company decided to defer drug price increases for no more than six months, following criticism from President Donald Trump for raising list prices of some medicines.
The units would be Innovative Medicines, Established Medicines and Consumer Healthcare. The company is currently split into two units - Innovative Medicines, which includes the consumer business, and Essential Health.
"This design gives us a sharper focus on diverse patients in diverse markets," Albert Bourla, chief operating officer said.
The Innovative Medicines business will now also include biosimilars and a new hospital business unit, and together with the Consumer Healthcare business, will account for about three-quarters of the company's revenue. Pfizer's 2017 annual revenue was $52.55 billion.
Pfizer said it would still evaluate options for its consumer healthcare business and expects to make a decision in 2018.
The company said in October last year that it was considering the sale or spin-off of the consumer healthcare business, which is worth about $15 billion. In May, Pfizer said that it had not received an acceptable offer.
The business consists of products ranging from Advil to lip balms.
The Established Medicines unit would include the majority of the company's off-patent brands, including Viagra and neurological disease treatment Lyrica as well as some generic drugs.
The changes would be effective at the start of fiscal 2019.
Pfizer shares slipped 0.7 percent.